Pharmaceutical Investing PADCEV Plus KEYTRUDA Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery 12 August
Pharmaceutical Investing Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer 08 August
Pharmaceutical Investing Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance 05 August
